104 related articles for article (PubMed ID: 12147668)
21. Interassay differences in growth hormone measurement in acromegaly.
Barth JH; Smith JH; Clarkson P
Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():156-9. PubMed ID: 9133248
[TBL] [Abstract][Full Text] [Related]
22. Skin tensile properties in patients treated for acromegaly.
Braham C; Betea D; Piérard-Franchimont C; Beckers A; Piérard GE
Dermatology; 2002; 204(4):325-9. PubMed ID: 12077539
[TBL] [Abstract][Full Text] [Related]
23. [Pegvisomant decreases growth hormone to nothing].
Krankenpfl J; 2004; 42(1-2):16-7. PubMed ID: 15116768
[No Abstract] [Full Text] [Related]
24. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
[TBL] [Abstract][Full Text] [Related]
25. Biochemical assessment of disease control in acromegaly: reappraisal of the glucose suppression test in somatostatin analogue (SA) treated patients.
Christiansen Arlien-Søborg M; Trolle C; Alvarson E; Bæk A; Dal J; Otto Lunde Jørgensen J
Endocrine; 2017 Jun; 56(3):589-594. PubMed ID: 28260207
[TBL] [Abstract][Full Text] [Related]
26. The role of radiotherapy in acromegaly.
van der Lely AJ; de Herder WW; Lamberts SW
J Clin Endocrinol Metab; 1997 Oct; 82(10):3185-6. PubMed ID: 9329335
[No Abstract] [Full Text] [Related]
27. Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking.
Ayuk J; Sheppard MC; Clayton RN; Bates AS; Stewart PM
J Clin Endocrinol Metab; 2004 Nov; 89(11):5867-8; author reply 5868. PubMed ID: 15531556
[No Abstract] [Full Text] [Related]
28. Fibroblast Growth Factor 21 in Patients with Acromegaly.
Halupczok-Żyła J; Jawiarczyk-Przybyłowska A; Skrzypski M; Strowski MZ; Bolanowski M
Exp Clin Endocrinol Diabetes; 2017 Nov; 125(10):649-654. PubMed ID: 28931175
[No Abstract] [Full Text] [Related]
29. Larger Than Life: A Unique Cause of Dyspnea in an Elderly Woman.
Kithcart AP; Beckman JA
Circulation; 2016 Aug; 134(9):689-93. PubMed ID: 27572881
[No Abstract] [Full Text] [Related]
30. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
31. Editorial: acromegaly--consensus, what consensus?
Trainer PJ
J Clin Endocrinol Metab; 2002 Aug; 87(8):3534-6. PubMed ID: 12161470
[No Abstract] [Full Text] [Related]
32. [Somatostatin agonists in the treatment of acromegaly].
Jaquet P; Morange-Rahos I; Janano B; Moati P; Brue T
Ann Endocrinol (Paris); 1998 Nov; 59(4):301-4. PubMed ID: 9864550
[No Abstract] [Full Text] [Related]
33. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
Hernandez I; Soderlund D; Espinosa-de-los-Monteros AL; Ochoa R; Zarate A; Mercado M
J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
[TBL] [Abstract][Full Text] [Related]
34. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency.
Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173
[TBL] [Abstract][Full Text] [Related]
35. Concomitant, specific determination of growth hormone and pegvisomant in human serum.
Ørskov H; Frystyk J; Nielsen C; Hansen AT; Weeke J; Jørgensen JO
Growth Horm IGF Res; 2007 Oct; 17(5):431-4. PubMed ID: 17574889
[TBL] [Abstract][Full Text] [Related]
36. [Consensus on the change of criteria for cure of acromegaly during the last decade].
Kovács GL; Dénes J; Hubina E; Kovács L; Czirják S; Góth M
Orv Hetil; 2011 May; 152(18):703-8. PubMed ID: 21498158
[TBL] [Abstract][Full Text] [Related]
37. Cancers associated with acromegaly.
Jenkins PJ
Neuroendocrinology; 2006; 83(3-4):218-23. PubMed ID: 17047386
[TBL] [Abstract][Full Text] [Related]
38. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
[TBL] [Abstract][Full Text] [Related]
39. The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery.
Wu TE; Lin HD; Lu RA; Wang ML; Chen RL; Chen HS
Growth Horm IGF Res; 2010 Dec; 20(6):411-5. PubMed ID: 20943425
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular Disease in Acromegaly.
Sharma MD; Nguyen AV; Brown S; Robbins RJ
Methodist Debakey Cardiovasc J; 2017; 13(2):64-67. PubMed ID: 28740584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
